Hesperidin opposes the negative impact of cyclophosphamide on mice kidneys

Drug Chem Toxicol. 2021 May;44(3):223-228. doi: 10.1080/01480545.2018.1560467. Epub 2019 Mar 20.

Abstract

The present investigation examined the prospective nephroprotective effect of hesperidin (HSN) in mice challenged with a single i.p. injection of cyclophosphamide (CPE) at a dose of 200 mg/kg. HSN (100 and 200 mg/kg/day, p.o.) was given for 10 days, starting 5 days prior to CPE administration. HSN significantly reduced the CPE-induced increments of serum creatinine and cystatin C. HSN also significantly reduced malondialdehyde, nitric oxide, Bax/Bcl-2 ratio, and caspase-3, and significantly raised total antioxidant capacity, and interleukin-10/tumor necrosis factor-α ratio in kidneys of mice received CPE. In addition, HSN significantly prevented the histopathological injury, and kidney injury molecule-1 expression in kidneys of mice given CPE. It was concluded that HSN guarded against nephrotoxic effect of CPE in mice by tackling oxidative/nitrative stress, inflammation, and apoptosis.

Keywords: Hesperidin; apoptosis; cyclophosphamide; inflammation; kidney; mice; oxidative stress.

MeSH terms

  • Animals
  • Antineoplastic Agents, Alkylating / toxicity
  • Antioxidants / metabolism
  • Apoptosis / drug effects
  • Creatinine / blood
  • Cyclophosphamide / toxicity*
  • Dose-Response Relationship, Drug
  • Hesperidin / administration & dosage
  • Hesperidin / pharmacology*
  • Inflammation / chemically induced
  • Inflammation / prevention & control
  • Kidney Diseases / chemically induced
  • Kidney Diseases / prevention & control*
  • Male
  • Mice
  • Oxidative Stress / drug effects*

Substances

  • Antineoplastic Agents, Alkylating
  • Antioxidants
  • Cyclophosphamide
  • Creatinine
  • Hesperidin